Sign in
WHWK Stock Price, Chart, Stats & News
Whitehawk Therapeutics Inc
Save
Whitehawk Therapeutics Inc (WHWK) does not currently pay a dividend.
213.21M
Market cap
–
Current P/E
2.66x
Forward P/E
WHWK chart
Fundamentals
Gross margin | 89.28% |
Operating margin | -1601.12% |
Pretax margin | -288.26% |
Net margin | -288.26% |
Effective tax rate | – |
ROA | -13.66% |
ROE | -11.99% |
D/E | – |
Interest coverage ratio | – |
WHWK valuation
P/E | – |
P/S | 20.87x |
P/B | 1.60x |
P/CF | -2.24x |
P/FCF | -1.52x |
P/OCF | -2.24x |
PEG | -0.05x |
EV multiple | -1.69x |
About
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021.
Similar securities
Based on sector and market capitalization
Report issue